Clinical TrialsSearch results
Number of results: 2568
Other
- A Phase I/Ib, Open-label, Multi-center Study of DFF332 as a Single Agent and in Combination With Everolimus or IO Agents in Patients With Advanced/Relapsed ccRCC and Other Malignancies With HIF2alpha Stabilizing Mutations
- Carcinoma, Renal Cell
- Yonemura Masataka
- 2021-08-13
Recruiting
- A Phase I/II Open-label Dose Escalation and Dose Expansion Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of AZD5863, a T cell-engaging Bispecific Antibody that Targets Claudin 18.2 (CLDN18.2) and CD3 in Adult Participants with Advanced or Metastatic Solid Tumors
- Gastric cancer Gastro-esophageal junction cancer Pancreatic ductal adenocarcinoma Esophageal aden
- Hibi Kazushige
- 2023-07-01
Other
- A PHASE I/II STUDY OF ATEZOLIZUMAB 1680 MG EVERY 4 WEEKS IN PATIENTS WITH ADVANCED SOLID TUMOR
- Advanced Solid Tumors
- Shunichiro Iwasawa
- 2022-06-21
Other
- A phase I/II study of hepatic arterial 5-flurouracil (5FU) combined with intravenous irinotecan hydrochloride (CPT-11) for metastatic colorectal cancer isolated in the liver. (JCOG 0208-DI)
- Metastatic colorectal cancer isolated in the liver
- Japan Clinical Oncology Group(JCOG)
- 2005-08-08
Recruiting
- A phase I/II study of human induced Pluripotent Stem (iPS) cell-derived cardiomyocyte spheroids in patients with severe heart failure, secondary to ischemic heart disease, undergoing coronary artery bypass grafting
- Heart failure with ischemic heart disease
- Kaneko Takehiko
- 2021-06-23
Completed
- A phase I/II study of hybrid brachytherapy for locally advanced cervical carcinoma
- Uterine cervical cancer
- Igaki Hiroshi
- 2019-03-12
Other
- A Phase I/II study of JR-031 for the patients of standard primary treatment-refractory acute graft-versus-host disease (acute GVHD) after hematopoietic stem cell transplantation
- Standard primary treatment-refractory acute GVHD
- JCR pharmaceuticals Co.,Ltd
- 2009-02-19
Recruiting
- A Phase I/II Study of necitumumab + carboplatin + nab-paclitaxel + pembrolizumab for previously untreated advanced squamous non-small cell lung cancer study
- squamous non-small cell lung cancer(SqCLC)
- Seike Masahiro
- 2021-10-22
Other
- A phase I/II study of percutaneous radiofrequency ablation for malignant lung tumor (JIVROSG-0203)
- Unresectable malignant lung tumor.
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2005-08-06
Other
- A phase I/II study of percutaneous vertebroplasty (JIVROSG-0202)
- Malignant vertebral bone tumor.
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2005-08-06